Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 33.3%High 2 · 66.7%

Overall survival · patients with EOC

1 finding from 1 review

Topotecan for ovarian cancer 2008 · Cochrane Headline outcomes only
no estimate extracted
1 study · 274 participants
High

Progression‐free survival · patients with EOC

1 finding from 1 review

Topotecan for ovarian cancer 2008 · Cochrane Headline outcomes only
no estimate extracted
1 study · 274 participants
High

Response to treatment · patients with EOC

Topotecan probably leads to higher response to treatment compared with treosulfan (moderate certainty).

1 finding from 1 review

Topotecan for ovarian cancer 2008 · Cochrane Headline outcomes only
RR 1.76 [1.06, 2.94]
1 study · 274 participants
Moderate